Clinical Trial Update: The Effect of VTC-G15 (a Pentapeptide Cleavage Product og GLP-1) on Whole Body Glucose Metabolism in Man [Phase 1]

View source ↗

Summary

This clinical trial update describes a Phase 1 study of VTC-G15, a pentapeptide cleavage product of GLP-1, assessing its effect on whole-body glucose metabolism…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insulin Resistance

Drugs mentioned

• VTC-G15 (VTC-G15)

Snippet

Sponsor: Elahi, Dariush, PhD | Conditions: Insulin Resistance | Phase 1 | Status: UNKNOWN